Find uplifting stories about heroes, innovations, and solutions
14 results for "pfizer"
After decades without a vaccine option, Pfizer's new Lyme disease vaccine showed over 70% effectiveness in preventing infection among 9,400 participants. The breakthrough could protect the 476,000 Americans infected annually from a disease that often leads to chronic arthritis and heart problems.
Egypt is teaming up with pharmaceutical giant Pfizer to manufacture vaccines and medicines right at home, reducing dependence on imports and strengthening healthcare for millions. The partnership could transform how the nation delivers critical treatments to its people.
Egypt's health ministry is teaming up with pharmaceutical giant Pfizer to expand cancer treatment, improve care for hemophilia patients, and manufacture vaccines locally. The partnership could transform healthcare access for millions across the nation.
For the first time in decades, a vaccine to prevent Lyme disease is showing real promise. Pfizer's new vaccine candidate demonstrated over 75% effectiveness in a major clinical trial, offering hope to millions who spend time outdoors.
Egypt is teaming up with pharmaceutical giant Pfizer to manufacture vaccines and medicines domestically, moving the country closer to healthcare independence. The partnership aims to reduce reliance on imports while expanding cancer care and training programs.
A promising new Lyme disease vaccine from Pfizer and Valneva could protect against nearly half a million annual U.S. infections. The shot targets bacteria inside ticks before they can infect people.
After more than 20 years without a Lyme disease vaccine in the U.S., Pfizer's new four-dose vaccine shows promising results that could protect millions from the most common tick-borne illness in America. The vaccine, tested across thousands of people in the U.S., Canada, and Europe, marks a hopeful step forward for outdoor enthusiasts and those living in high-risk areas.
Pfizer and Valneva's experimental Lyme disease vaccine proved highly effective in Phase III trials, bringing hope to millions who love the outdoors. If approved, it would be the first Lyme vaccine available in two decades.
After decades without a Lyme vaccine, Pfizer's new candidate proved more than 70% effective at preventing the disease in a major clinical trial. The breakthrough brings hope to millions who face the threat of this debilitating illness every time they step outdoors.
A groundbreaking Lyme disease vaccine has proven 73% effective in major trials, bringing hope to millions at risk from tick-borne illness. After decades without protection, regulatory approval could arrive soon for people ages five and up.
A new vaccine could soon protect people from Lyme disease for the first time in over 20 years. Pfizer and Valneva's candidate showed over 70% effectiveness in preventing the tick-borne illness that affects hundreds of thousands annually.
A new Lyme disease vaccine from Pfizer has shown 70% effectiveness in clinical trials, offering hope for protection against the tick-borne illness that affects hundreds of thousands annually. This marks the first promising Lyme vaccine in over two decades.
A new drug combination could help prostate cancer patients earlier in their fight, reducing the risk of tumor growth by more than expected in a major clinical trial. The treatment targets a specific genetic mutation found in 1 in 4 metastatic prostate cancer cases.
Pfizer's experimental drug combination reduced cancer progression risk by 40% in patients whose breast cancer returned after standard treatment. The breakthrough offers new hope for hard-to-treat cases where current therapies have failed.